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Essentials: 
 It is debated whether physical activity influences the risk of venous thromboembolism. 
 The association was explored to account for fluctuations in physical activity over time. 
 Overall and in the elderly, physical activity (≥1h/week) was associated with 23% and 30% 
lower risk. 
 A moderate proportion of the association (14-36%) was mediated via body mass index. 
 
Abstract 
Background: Whether physical activity influences the risk of incident venous thromboembolism 
(VTE) remains controversial, potentially due to methodological challenges, such as regression 
dilution bias. 
Objectives: To investigate whether physical activity was associated with VTE risk, and explore the 
role of body mass index (BMI) as a mediator in a population-based cohort with repeated 
assessments of physical activity. 
Methods: Participants (n=30 002) attending one or more surveys of the Tromsø Study 4-6 (1994-95, 
2001-02, 2007-08) were included and categorized based on weekly physical activity. Incident VTE 
was registered until December 31, 2016. Hazard ratios (HRs) were calculated using time-varying Cox 
regression models. The Aalen additive hazard model was used to quantify the total, direct and 
indirect effect of physical activity. 
Results: There were 531 incident VTEs during follow-up. Physical activity (≥1/week) was associated 
with lower risk of VTE (HR 0.77, 95% CI 0.64-0.92) compared to inactive. The effect was most 
pronounced for those ≥65 years (HR 0.70, 95% CI 0.55-0.88) and provoked events (HR 0.66, 95% CI 
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0.14) and -1.59 (95% CI -2.74 to -0.52) events annually per 1 000 individuals in the total and elderly 
population, respectively. A moderate proportion of the association (14-36%) was mediated via BMI. 
Conclusion: Our findings suggest that regular physical activity is associated with lower risk of VTE, 
particularly in elderly. The association occurred at a low weekly amount of physical activity, and was 
only partly mediated by BMI. 
 
Keywords: Epidemiology – Exercise – Physical activity – Risk factors – Venous thromboembolism  
Introduction 
Venous thromboembolism (VTE) affects 1-2 per 1000 individuals annually, and represents a 
significant public health burden due to debilitating complications, high recurrence rates and a 
potentially fatal outcome [1-4]. The individual susceptibility to VTE depends on complex interactions 
between inherited, acquired and environmental factors with accompanying changes in the vessel 
wall, blood flow or blood composition of sufficient magnitude to exceed the thrombosis threshold 
[5, 6]. Despite increased awareness and preventive measures, the age-adjusted incidence rate of VTE 
has remained stable or increased slightly during the past decades [2, 7]. Moreover, with a growing 
prevalence of important risk factors, such as cancer, obesity and an aging population, the total 
number VTE events may rise further in the coming years [8-10]. Hence, identification of modifiable 
risk factors at the population level is imperative to combat the growing burden of VTE. 
Inadequate physical activity is a well-known risk factor for arterial thrombotic diseases [11, 
12]. However, despite a bidirectional relationship between arterial and venous thromboembolic 
diseases [13-15], the association between physical activity and VTE risk remains unsettled. Several 
studies have suggested that a moderate amount of weekly physical activity is associated with lower 
risk of incident VTE when compared to no or a low amount of physical activity [16-20]. Specifically, a 
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the REGARDS Study [17]. However, except for the REGARDS Study, there is limited evidence of a 
dose-response relationship between physical activity and VTE risk [16-18]. On the contrary, it has 
been suggested that strenuous activity may be associated with an increased risk of VTE [18, 21], 
particularly in the elderly [22]. Still, findings from several large cohort studies suggest that physical 
activity does not influence the risk of VTE in either direction [23-27]. 
 Despite an apparently complex picture, some trends may be deduced from the available 
literature. First, studies reporting no association between physical activity and VTE risk are 
characterized by a relatively long follow-up [23-26]. Due to the potential fluctuating nature of 
physical activity, the risk estimates in these studies may be underestimated due to regression 
dilution [28, 29]. To date, we are aware of only two studies, restricted to middle-aged [16] and 
elderly [22], which have accounted for changes in activity habits during follow-up. Further, studies 
with a retrospective assessment strategy have consistently reported a beneficial association [19, 20]. 
However, these findings may be subject to recall bias, and should be interpreted with caution [30]. 
In most studies, body mass index (BMI) has been treated as a confounder of the association between 
physical activity and VTE [16, 18, 23, 24]. However, as physical activity is important in weight 
maintenance [12, 31], BMI may be considered as an intermediate, rather than a confounder, in the 
pathway between physical activity and VTE risk. Therefore, the aims of the present study were (i) to 
investigate the association between habitual physical activity and the risk of incident VTE in a 
population-based cohort with repeated assessments of physical activity and observation periods of 




A total of 30 586 participants were recruited from the fourth (1994-95), fifth (2001-02) and sixth 
(2007-08) surveys of the Tromsø Study, a prospective population-based study with repeated health 
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Tromsø Study have been described previously [32]. Briefly, the participation rates were 77% in 
Tromsø 4, 79% in Tromsø 5 and 66% in Tromsø 6, and the participants were aged 25 to 89 years at 
inclusion. Individuals who did not consent to medical research (n=181), were not officially registered 
as inhabitants of the Tromsø municipality at baseline (n=23), with a pre-baseline history of VTE 
(n=85), and with missing data on physical activity (n=295), were excluded. Accordingly, 30 002 
individuals were included in the present study. Those attending two (n=8541) or three (n=3397) 
surveys had their exposure data updated and contributed with observation periods corresponding to 
the number of surveys they participated in, yielding a total of 45 337 observation periods. The study 
was approved by the Regional Committee for Medical and Health Research Ethics, and all 
participants signed an informed consent form prior to inclusion. 
 
Measurements 
Information at baseline and subsequent visits was obtained by physical examinations, blood samples 
and self-administered questionnaires. Height and weight were measured with participants wearing 
light clothes and no shoes, and BMI was calculated as weight in kilograms divided by the square of 
height in meters (kg/m2). Information on leisure-time physical activity, smoking habits, education, 
diabetes, and history of cardiovascular disease (CVD; angina pectoris, myocardial infarction and 
stroke), was collected via self-administered questionnaires. Data on cancer history was obtained 
from the Cancer Registry of Norway. 
 
Assessment and categorization of leisure time physical activity 
In Tromsø 4 and 5, participants reported their average weekly time spent in light physical activity 
(not sweating or out of breath) and hard physical activity (causing sweating and breathlessness) 
during leisure time in the past year according to four categories: ‘none’, ‘<1 hour’, ‘1-2 hours’, or ‘≥3 
hours’. The reliability of the question on hard physical activity has been shown to be moderate, and 
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the International Physical Activity Questionnaire (IPAQ) [33]. The question on light physical activity is 
reported to be less reliable and less well correlated with objective measures [33]. In Tromsø 6, the 
participants reported their weekly frequency of exercise (‘never’, ‘less than once’, ‘once’, ‘2-3 times’ 
or ‘approximately every day’), intensity (‘not short-winded or sweaty’, ‘becoming short-winded or 
sweaty’ or ‘becoming exhausted’), and average duration per session (‘<15 minutes’, ‘15-29 minutes’, 
‘30-60 minutes’ or ‘>1 hour’). The reliability of the questionnaire is reported to be high, and it is well 
correlated with objective measures of physical activity, IPAQ and VO2max [34]. Total weekly duration 
of physical activity was calculated as the sum of the reported frequency per week and duration per 
session, and activity categories equal to those in Tromsø 4 and 5 were created. The lowest intensity-
category was considered as equivalent to light physical activity in Tromsø 4 and 5, and the two upper 
intensity-categories were assumed to reflect hard physical activity. Those who did not report on the 
intensity question, but provided information on frequency and duration, were placed in the lowest 
intensity category. 
We further constructed a common five-level variable with one inactive group that comprised 
of participants reporting ‘no activity’ or ‘less than 1 hour per week’, and four active groups: ‘1-3 
hours/week of light activity’, ‘>3 hours/week of light activity’, 1-3 hours/week of hard activity’ and 
‘>3 hours/week of hard activity’. The categorization was based on a combination of the light and 
hard physical activity questions (Table S1), and was an attempt to apprehend the larger physiological 
responses with increasing intensity and amount of physical activity [35]. We also created a 
dichotomous activity variable, where the four active groups were merged (i.e., ‘≥1 hour/week’) and 
compared to the inactive group (i.e., ‘no activity’ or ‘<1 hour/week’). 
 
Identification and adjudication of venous thromboembolism 
All incident VTE events were identified by searching the hospital discharge registry (both outpatient 
visits and hospitalizations), the autopsy registry and the radiology procedure registry at the 










This article is protected by copyright. All rights reserved. 
08) to December 31, 2016. UNN is the only hospital in the study region, and all hospital care and 
relevant diagnostic radiology is provided exclusively by this hospital. Trained personnel adjudicated 
and recorded each VTE event by extensive review of the medical records. The adjudication criteria 
for VTE were presence of signs and symptoms of pulmonary embolism (PE) or deep vein thrombosis 
(DVT) combined with objective confirmation by radiological procedures, which resulted in treatment 
initiation (unless contraindications were specified). The process of case identification and 
adjudication has previously been described in detail [36]. 
All VTE events were classified as either DVT or PE (with or without DVT), and as unprovoked 
or provoked. The following factors were regarded as provoking: recent surgery or trauma (within 8 
weeks prior to the event), acute medical conditions (acute myocardial infarction, ischemic stroke, or 
major infectious disease), active cancer, marked immobilization (bedrest ≥3 days, confined to 
wheelchair, or long-distance travel ≥4 h within the previous 14 days), or another provoking factor 
described by the physician in the medical record (e.g., intravascular catheters). 
 
Statistical analysis 
For each participant, person-years of follow-up were accrued from the date of enrolment to the date 
of incident VTE, death, migration or to the end of the observation period, whichever came first. Each 
observation period ended on the date of the next possible survey for participants enrolled in Tromsø 
4 (1994/95-2002) or Tromsø 5 (2001/02-2008), while follow-up for Tromsø 6 (2007/08) ended on 
December 31, 2016. Participants attending only Tromsø 4 and 6 did not contribute with person-
years between Tromsø 5 and 6 (Fig. 1). Participants who experienced a VTE event in one observation 
period, were excluded from subsequent periods. During follow-up, 4940 participants moved from 
the Tromsø municipality and 4975 participants died. 
Crude incidence rates (IRs) for VTE were calculated across categories of physical activity and 
expressed as number of events per 1000 person-years. Hazard ratios (HRs) with 95% confidence 
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time-varying Cox proportional hazards regression models with the least active group (‘no activity’ or 
‘>1 hour/week’) as the reference. A test for linear trend across categories was conducted by entering 
the categorical variable as an ordinal variable in the proportional hazards regression model. Age was 
used as time-scale, with the age at enrolment defined as entry time and the age at VTE or censoring 
defined as exit time. The analyses were performed in three models. Model 1 included age (time 
scale) and sex, model 2 included model 1 + BMI, and model 3 included model 2 + history of CVD and 
cancer. There were 44 participants with missing information on BMI, and these were omitted from 
multivariable analyses only. HRs were estimated for the total study population, and for subgroups 
stratified by age at inclusion (<65 or ≥65 years). Percentage changes in HRs between models were 
calculated with the formula: ([HRadjusted – HRunadjusted]/[HRunadjusted - 1]) x 100% [37]. The proportional 
hazards assumption was evaluated and verified on the basis of Schoenfeld residuals using a global 
test. Statistical interactions between physical activity and BMI (physical activity*BMI) and sex 
(physical activity*sex) were tested by including the cross-product terms separately in the 
multivariable adjusted proportional hazard model, and no interactions were found. 
The population attributable fraction, which is the proportion of VTE events in the study 
population attributed to inactivity, was calculated from IRs of VTE in the general population (IRp) and 
in the physically active population (IRa), by the formula ([IRp – IRa]/[IRp]) x 100% [13]. Calculations 
were done for the total study population and separately for those aged <65 years and ≥65 years. 
The total, direct and indirect (mediated by BMI) effects of physical activity on the risk of VTE 
were quantified on basis of the Aalen additive hazard model [38]. This method provides an estimate 
of the absolute differences in risk per unit time with 95% CI for a given change in exposure status 
(e.g., inactive to active), which can be divided into a part attributed to a direct pathway and a part 
attributed to an indirect pathway.  
Statistical analyses were performed with STATA version 15.0 (Stata Corp, College Station, TX, 
USA) and R version 3.4.3 (The R Foundation for Statistical Computing, Vienna, Austria). The level of 
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Results 
Mean age at inclusion was 47 ± 15 years and 52.4% of the participants were women. During 341 451 
person-years of follow-up (mean duration per observation period was 6.8 ± 1.6 years), there were 
531 incident VTE events yielding a crude incidence rate of 1.56 per 1000 person-years (95% CI 1.43-
1.69). Baseline characteristics across categories of physical activity are shown in Table 1. Although 
the proportion of inactive was similar in men and women, active women were more likely to engage 
in light physical activity and active men in hard physical activity. Further, individuals participating in 
hard physical activity were younger, had a more favorable cardiovascular risk profile and were less 
likely to have a history of CVD and cancer, compared to those in the other categories. 
Characteristics of the VTE events are presented in Table 2. Mean age at incident VTE was 68 
± 12 years. The most common clinical presentation was DVT, accounting for 59% of the cases, while 
the remaining 41% presented as PE with or without concurrent DVT. Further, 60% of the events 
were classified as provoked, and cancer was the most common provoking factor, accounting for 26% 
of the cases. 
Total and age-stratified IRs and HRs for VTE by the five categories of weekly physical activity 
are shown in Table 3. In the age- and sex-adjusted model, there was a significant trend of a lower 
risk of VTE across activity categories (p=0.008). However, the largest decrease in risk (22% lower risk) 
occurred between the two lowest activity categories (from ‘no activity’ or ‘<1 hour/week’ to ‘1-3 
hours/week of light activity’) and the confidence intervals of the risk estimates for the remaining 
categories largely overlapped. The risk estimates were attenuated after adjustment for BMI (16% 
lower risk), while adjustment for history of CVD and cancer did not further influence the risk 
estimates. Analyses stratified by age at baseline (<65 or ≥65 years) revealed that the association was 
most pronounced in those aged ≥65. Here, there was a significant trend of a lower risk of VTE across 
categories of physical activity (p 0.004), which remained statistically significant after adjusting for 
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occurred between the two lowest categories, with overlapping confidence intervals for the 
remaining categories. 
Total and age-stratified IRs and HRs for VTE according to activity status are shown in Table 4. 
In the age- and sex-adjusted model, active individuals had 23% lower risk of VTE (HR 0.77, 95% CI 
0.61-0.92) compared to inactive. The risk estimate was attenuated when adjusting for BMI (16% 
lower risk), while adjusting for history of CVD and cancer did not further modify the association. In 
those ≥65 years, physical activity was associated with a 30% lower risk of VTE (HR 0.70, 95% CI 0.55-
0.88). The association was attenuated, but still significant, when adjusting for BMI and history of 
CVD and cancer (25% and 24% lower risk, respectively). In those <65 years, physical activity was 
associated with 15% lower risk, but the risk estimate was not statistically significant (HR 0.85, 95% CI 
0.64-1.13). The proportion of VTE events attributable to physical inactivity was 12.2%, 6.0% and 
12.5% for the total study population, in those <65 years and in those ≥65 years, respectively. 
Separate analyses for unprovoked and provoked VTE are shown in Table 5 and in Table S2. 
For both outcomes, the risk estimates suggested a beneficial effect of participating in physical 
activity, with the largest effect sizes observed in those ≥65 years and in relation to provoked events. 
Elderly who were physically active had a 34% lower risk of provoked VTE (HR 0.66, 95% CI 0.50-0.89) 
compared to those who were inactive, and the association remained significant after adjusting for 
BMI and history of CVD and cancer (28% and 27% lower risk, respectively). There was also a trend of 
a lower risk of unprovoked VTE in those ≥65 years (HR 0.76, 95% CI 0.52-1.13). Further, we 
performed analyses separately for PE and DVT (Table 6 and Table S3). In those aged ≥65, physical 
activity was associated with a lower risk of PE (HR 0.69, 95% CI 0.48-0.98) and DVT (HR 0.70, 95% CI 
0.52-0.96), which was attenuated when adjusting for BMI. In those <65 years, there was a trend of a 
beneficial association in relation to PE (HR 0.67, 95% CI 0.43-1.04), but not DVT (HR 1.00, 95% CI 
0.69-1.45). 
The total, direct and indirect (mediated via BMI) effects of physical activity on VTE risk 
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difference between active and inactive was -0.42 (95% CI -0.73 to -0.14) per 1 000 at risk annually, of 
which 23% (95% CI 11-68) was attributed to BMI. The corresponding differences in risks in those <65 
and ≥65 years were -0.20 (-0.42 to -0.07) and -1.59 (-2.74 to -0.52) per 1 000 persons at risk per year, 
respectively. A relatively larger proportion of the effect was mediated via BMI in those aged <65 (36 
%, 95% CI 15-90) than those aged ≥65 (14%, 95% CI 5-48). 
 
Discussion 
Our main findings were that (i) there was an inverse association between participation in physical 
activity and VTE risk, but not in a dose-dependent manner; (ii) a moderate proportion of the 
association was mediated via BMI-related pathways; and (iii) the association was strongest in those 
aged ≥65 years and in relation to provoked events. 
Whether habitual physical activity influences the risk of VTE has been the focus of several 
investigations, and diverging results have been reported. Our findings, along with results from three 
previously published cohort studies, suggest that a moderate amount of physical activity may lower 
the risk of VTE [16-18]. In the ARIC Study, more than 15 000 middle-aged adults were followed for an 
average of 15.5 years, and physical activity was reassessed once during follow-up [16]. Individuals in 
activity categories 2-4, assessed with the Baecke sports questionnaire, had 19-31% lower risk of VTE 
compared to those in category 1 [16]. Likewise, in the REGARDS Study, participation in physical 
activity 1-3 times and ≥4 times per week was associated with 30% and 41% lower risk of VTE, 
respectively, compared to no activity [17]. In the Million Women Study, a cohort of 1.1 million 
middle-aged women, those reporting at least some weekly physical activity had 4-18% lower risk of 
VTE, compared to those who were inactive [18]. 
We previously reported on the association between moderate and high intensity physical 
activity assessed at the time of inclusion and the risk of incident VTE in the Tromsø Study [23]. 
Almost 25 000 participants were followed for a median of 12.5 years, and no association was 
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status recorded at baseline only, modifiable risk factors, such as physical activity, represent a 
challenge [28, 29]. Participants who change behavior during follow-up will be misclassified (non-
differential), which typically leads to regression dilution and underestimation of the true association 
[28]. In the present study, we were able to address this challenge because exposure status was 
updated for those who took part in several surveys, and the duration of each observation period was 
kept relatively short (<7 years). This is likely to reduce regression dilution bias, and may, in addition 
to increased power, explain why the present findings differ from our previous report. 
In the present study, the largest difference in risk was observed between the inactive and 
the lowest activity category, with modest additional benefits of higher amounts of physical activity. 
This is in line with previous findings [16, 18], and indicates that avoiding an inactive lifestyle may be 
sufficient to lower the risk of VTE. It also coheres with the fact that immobility and other 
circumstances associated with physical restriction are strongly associated with an elevated VTE risk 
[39-42]. At the other extreme, it has been suggested that high amounts of strenuous physical activity 
may increase the risk of VTE [18, 22]. Specifically, in the CHS, a cohort of adults aged ≥65 years, 
participation in strenuous physical activity was associated with a 75% higher risk of VTE compared to 
being inactive [22]. In contrast, our findings suggested that the beneficial effect of physical activity 
was largely restricted to those aged ≥65 years. The diverging results may be explained by different 
assessment and categorization of physical activity, as the beneficial effect in our study applied to 
physical activity in general, while the harmful effect in the CHS was restricted to strenuous activity. 
We found that active individuals aged ≥65 had 30% lower risk of VTE compared to those who 
were inactive, and that 12.5% of VTE events in this population could be attributed to inactivity. 
When expressed in the additive hazard model, this translated into an annual difference in absolute 
risk of 1.6 per 1000. Alongside the high prevalence of physical inactivity [43], this suggests that a 
successful population strategy to reduce inactivity could have a notable impact on the incidence of 
VTE, particularly in the elderly. Although VTE may occur in people of all ages, it is relatively 
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strong risk factors need to be present simultaneously to exceed the thrombosis threshold. 
Accordingly, the potential risk modification obtained with physical activity may be too small to elicit 
a detectable effect in young individuals. Further, in those ≥65 years, the lower risk, particularly of 
provoked events, may be partly mediated by a lower incidence of VTE-associated diseases. Although 
our multivariable adjusted analyses showed that history of CVD and cancer did not modify the risk 
estimates, the potential of residual confounding remains. 
Obesity is a well-recognized risk factor for VTE [44, 45], and BMI is usually treated as a 
confounding variable in analyses of the association between physical activity and VTE risk [16, 18, 
23, 24]. In our study, the risk estimates were attenuated by 12% in young adults and 7% in the 
elderly when BMI was added to the regression models. However, as physical activity is important in 
weight maintenance [12, 31], it is reasonable to consider BMI as an intermediate in the causal 
pathway between physical activity and VTE. By applying the Aalen additive hazard model, we 
showed that a low to moderate proportion of the total effect of physical activity on VTE risk was 
mediated by BMI. Thus, although BMI-related pathways mediated some of the effect, our findings 
suggest that the beneficial effect of physical activity on VTE risk may primarily be ascribed to other 
mechanisms than those associated with weight status. 
The main strengths of the present study include a large number of participants recruited 
from a general population, high participation rates, wide age distribution, prospective design with 
repeated measurements for a part of the study population, and thoroughly validated outcomes. As 
UNN is the only provider of hospital care in the study region, a near complete VTE register can be 
anticipated. To our knowledge, this is also the first study to apply mediation analyses to quantify the 
role of BMI as a mediator in the relationship between physical activity and VTE. Some limitations of 
the study need to be considered. The analyses were restricted to participants who had provided 
information on their physical activity habits (99% of the participants), and the responders may differ 
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report, there is a chance for misclassification (e.g., due to challenges with recall or social 
desirability). However, as exposure data was collected prior to the occurrence of potential disease, 
such misclassification is likely independent of the outcome and not a threat to the internal validity of 
the study. Still, objective assessment strategies (e.g., cardiorespiratory fitness) have a higher level of 
precision and are reported to be superior predictors of all-cause and cancer-related mortality [46, 
47]. Interestingly, an association between cardiorespiratory fitness in early adulthood and future risk 
of unprovoked VTE was reported in a recent study [48]. A methodological challenge in our study was 
the use of different questionnaires to assess physical activity in the different surveys of the Tromsø 
Study. However, the activity categories showed meaningful associations with cardiometabolic 
markers, which supports the validity of the variable. Finally, as measures of physical activity and BMI 
used in the mediation analysis were assessed cross-sectionally, the temporal sequence is unknown, 
and the results must be interpreted under the assumption that BMI is at least partly determined by 
physical activity [31]. 
In conclusion, we found that weekly participation in physical activity was associated with 
lower the risk of incident VTE, particularly in participants aged ≥65 years and for provoked events. 
The association was only partly mediated by BMI, and appeared to be independent of history of CVD 
and cancer. Future studies applying objective assessment strategies of physical activity and physical 
fitness are warranted to confirm the association. 
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Tables and figures 
 
Table 1 Baseline characteristics of participants (n= 30 002) across categories of weekly physical 




Inactive* 1-3 h light PA† >3 h light PA† 1-3 h hard PA‡ >3 h hard PA‡ 
Number of participants 7237 7148 6170 6309 3138 
Age, years 50 (16) 47 (14) 50 (16) 42 (12) 41 (12) 
Sex (women) 52.3 (3787) 58.5 (4181) 60.5 (3733) 47.1 (2974) 34.6 (1087) 
BMI, kg/m2 26.0 (4.4) 25.4 (4.0) 25.1 (3.8) 24.9 (3.5) 24.7 (3.2) 
Triglycerides, mmol/L 1.71 (1.15) 1.57 (1.04) 1.50 (0.97) 1.45 (0.99) 1.44 (1.02) 
Total cholesterol, mmol/L 6.14 (1.36) 6.09 (1.30) 6.15 (1.33) 5.69 (1.19) 5.64 (1.18) 
HDL cholesterol, mmol/L 1.45 (0.40) 1.50 (0.41) 1.54 (0.42) 1.49 (0.40) 1.50 (0.41) 
Systolic blood pressure, mmHg 136 (23) 134 (20) 136 (22) 130 (18) 131 (17) 
Smoking 40.1 (2899) 37.6 (2685) 36.6 (2258) 30.4 (1916) 29.3 (920) 
Higher education§ 23.6 (1696) 29.1 (2074) 28.8 (1765) 45.4 (2964) 41.3 (1292) 
History of CVD 9.6 (692) 6.2 (440) 8.0 (491) 2.7 (171) 2.7 (85) 
History of cancer 3.7 (269) 2.8 (199) 3.6 (224) 1.9 (117) 1.6 (49) 
 
BMI body mass index, CVD cardiovascular disease (angina pectoris, stroke, myocardial infarction), h hours, HDL high-
density lipoprotein, PA physical activity 
*Less than 1 h of physical activity per week 
†Activity at an intensity not causing breathlessness and sweating 
‡Activity at an intensity causing breathlessness and sweating 
§≥15 years of education (corresponding to 3 years in university or academy) 
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Table 2 Characteristics of VTE events (n=531). The Tromsø Study (1994-2016) 
 
 % (n) 
Age, years (mean, SD) 68 (12) 
Sex (women) 50.1 (266) 
Clinical characteristics  
   Pulmonary embolism 40.7 (216) 
   Deep vein thrombosis 59.3 (315) 
   Provoked 60.5 (321) 
   Unprovoked* 39.5 (210) 
Provoking factors†  
   Surgery 18.3 (97) 
   Trauma 8.5 (45) 
   Acute medical condition 12.8 (68) 
   Cancer  26.2 (139) 
   Immobilization‡ 17.0 (90) 
   Other§ 5.3 (28) 
Clinical risk factors  
   Estrogens (HRT, oral contraceptives) 4.9 (26) 
   Heredity¶ 2.8 (15) 
   Pregnancy/postpartum 0.8 (4) 
   Other medical conditions** 21.9 (100) 
 
HRT hormone replacement therapy, SD standard deviation, VTE venous thromboembolism 
*No provoking factors at the time of diagnosis 
†One patient may have multiple provoking factors 
‡Bed rest ≥3 days, long-distance travel ≥4 h within the previous 14 days, or confined to wheelchair 
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¶Reported family history of VTE in first-degree relative(s) before the age of 60 
**Other diseases within the previous year (myocardial infarction, ischemic stroke heart failure, inflammatory bowel 
disease, or myeloproliferative disorders) 
Values are percentage (count) unless otherwise noted 
 
 
Table 3 Age-stratified incidence rates and hazard ratios with 95% confidence intervals for total VTE 








 (95% CI)* 
HR model 1 
 (95% CI)† 
HR Model 2 
 (95% CI)‡ 
HR Model 3 
 (95% CI)§ 
All       
Inactive 92 765 190 2.05 (1.78-2.36) 1.00 1.00 1.00 
Light PA 1-3 h 72 979 111 1.52 (1.27-1.83) 0.78 (0.62-0.99) 0.84 (0.66-1.06) 0.84 (0.66-1.06) 
Light PA >3 h 59 092 107 1.81 (1.50-2.19) 0.80 (0.63-1.01) 0.89 (0.70-1.14) 0.89 (0.70-1.14) 
Hard PA 1-3 h 81 534 88 1.08 (0.88-1.33) 0.74 (0.58-0.96) 0.81 (0.63-1.05) 0.82 (0.63-1.06) 
Hard PA >3 h 35 082 35 1.00 (0.72-1.39) 0.69 (0.48-0.99) 0.77 (0.54-1.12) 0.79 (0.55-1.13) 
p for trend    0.008 0.084 0.101 
Age <65 years       
Inactive 71 402 71 0.99 (0.79-1.25) 1.00 1.00 1.00 
Light PA 1-3 h 56 236 44 0.78 (0.58-1.06) 0.84 (0.57-1.22) 0.91 (0.63-1.33) 0.91 (0.62-1.33) 
Light PA >3 h 41 448 35 0.84 (0.60-1.18) 0.86 (0.60-1.29) 0.97 (0.65-1.47) 0.96 (0.64-1-45) 
Hard PA 1-3 h 71 506 57 0.80 (0.61-1.03) 0.91 (0.64-1.29) 1.00 (0.52-1.44) 1.01 (0.71-1.43) 
Hard PA >3 h 30 428 19 0.62 (0.40-0.98) 0.75 (0.45-1.24) 0.87 (0.52-1.44) 0.87 (0.52-1.45) 
p for trend    0.372 0.83 0.85 
Age ≥65 years       
Inactive 21 363 119 5.57 (4.65-6.67) 1.00 1.00 1.00 

















CI confidence interval, h hour, HR hazard ratio, IR incidence rate, PA physical activity, VTE venous thromboembolism 
*Per 1000 person-years 
†Adjusted for age (as timescale) and sex 
‡Model 1 + body mass index 




Light PA >3 h 17 644 72 4.08 (3.24-5.14) 0.74 (0.55-0.99) 0.81 (0.60-1.09) 0.81 (0.60-1.09) 
Hard PA 1-3 h 10 029 31 3.09 (2.17-4.40) 0.58 (0.39-0.87) 0.63 (0.42-0.94) 0.63 (0.42-0.95) 
Hard PA >3 h 4654 16 3.44 (2.11-5.61) 0.64 (0.38-1.08) 0.70 (0.41-1.19) 0.72 (0.42-1.22) 
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Table 4 Total and age-stratified incidence rates and hazard ratios with 95% confidence intervals for 








 (95% CI)* 
HR model 1 
 (95% CI)† 
HR Model 2 
 (95% CI)‡ 
HR Model 3 
 (95% CI)§ 
All       
   Inactive¶ 92 765 190 2.05 (1.78-2.36) 1.00 1.00 1.00 
   Active** 248 687 341 1.37 (1.23-1.52) 0.77 (0.64-0.92) 0.84 (0.70-1.01) 0.84 (0.70-1.01) 
Age <65 years       
   Inactive¶ 71 402 71 0.99 (0.78-1.25) 1.00 1.00 1.00 
   Active** 199 618 155 0.78 (0.66-0.91) 0.85 (0.64-1.13) 0.95 (0.71-1.26) 0.95 (0.71-1.26) 
Age ≥65 years       
   Inactive¶ 21 363 119 5.57 (4.65-6.67) 1.00 1.00 1.00 
   Active** 49 068 186 3.79 (3.28-4.38) 0.70 (0.55-0.88) 0.75 (0.59-0.95) 0.76 (0.60-0.96) 
 
CI confidence interval, HR hazard ratio, IR incidence rate, VTE venous thromboembolism 
*Per 1000 person-years 
†Adjusted for age (as timescale) and sex 
‡Model 1 + body mass index 
§Model 2 + history of cardiovascular disease and cancer 
¶<1 hour/week of physical activity 
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Table 5 Overall and age-stratified incidence rates and hazard ratios with 95% confidence intervals for 








 (95% CI)* 
HR model 1 
 (95% CI)† 
HR Model 2 
 (95% CI)‡ 
HR Model 3 
 (95% CI)§ 
PROVOKED  VTE       
All       
   Inactive¶ 92 765 118 1.27 (1.06-1.52) 1.00 1.00 1.00 
   Active** 248 687 203 0.82 (0.71-0.94) 0.74 (0.59-0.93) 0.80 (0.64-1.01) 0.81 (0.64-1.02) 
Age <65 years       
   Inactive¶ 71 402 40 0.56 (0.41-0.76) 1.00 1.00 1.00 
   Active** 199 618 86 0.43 (0.35-0.53) 0.84 (0.58-1.22) 0.92 (0.63-1.34) 0.92 (0.63-1.34) 
Age ≥65 years       
   Inactive¶ 21 363 78 3.65 (2.92-4.56) 1.00 1.00 1.00 
   Active** 49 068 117 2.38 (1.99-2.86) 0.66 (0.50-0.89) 0.72 (0.54-0.97) 0.73 (0.54-0.98) 
UNPROVOKED VTE        
All       
   Inactive¶ 92 765 72 0.78 (0.62-0.98) 1.00 1.00 1.00 
   Active** 248 687 138 0.55 (0.47-0.66) 0.81 (0.61-1.08) 0.90 (0.67-1.21) 0.91 (0.68-1.21) 
Age <65 years       
   Inactive¶ 71 402 31 0.43 (0.31-0.62) 1.00 1.00 1.00 
   Active** 199 618 69 0.35 (0.27-0.44) 0.88 (0.57-1.34) 0.99 (0.65-1.53) 0.99 (0.64-1.52) 
Age ≥65 years       
   Inactive¶ 21 363 31 1.92 (1.41-2.61) 1.00 1.00 1.00 
   Active** 49 068 69 1.41 (1.11-1.78) 0.76 (0.52-1.13) 0.82 (0.55-1.22) 0.82 (0.55-1.22) 
 
CI confidence interval, HR hazard ratio, IR incidence rate, VTE venous thromboembolism 
*Per 1000 person-years 
†Adjusted for age (as timescale) and sex 
‡Model 1 + body mass index 
§Model 2 + history of cardiovascular disease and cancer 
¶<1 hour/week of physical activity 
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Table 6 Overall and age-stratified incidence rates and hazard ratios with 95% confidence intervals for 







 (95% CI)* 
HR model 1 
 (95% CI)† 
HR Model 2 
 (95% CI)‡ 
HR Model 3 
 (95% CI)§ 
PULMONARY 
EMBOLISM 
      
All       
   Inactive¶ 92 765 83 0.89 (0.73-1.11) 1.00 1.00 1.00 
   Active** 248 687 133 0.53 (0.45-0.63) 0.69 (0.52-0.91) 0.77 (0.58-1.02) 0.77 (0.58-1.02) 
Age <65 years       
   Inactive¶ 71 402 32 0.45 (0.32-0.63) 1.00 1.00 1.00 
   Active** 199 618 53 0.27 (0.20-0.35) 0.67 (0.43-1.04) 0.77 (0.49-1.20) 0.76 (0.49-1.19) 
Age ≥65 years       
   Inactive¶ 21 363 51 
2.39 (1181-
3.14) 
1.00 1.00 1.00 
   Active** 49 068 80 1.63 (1.31-2.03) 0.69 (0.48-0.98) 0.76 (0.53-1.09) 0.76 (0.53-1.09) 
DEEP VEIN 
THROMBOSIS  
      
All       
   Inactive¶ 92 765 107 1.15 (0.95-1.39) 1.00 1.00 1.00 
   Active** 248 687 208 0.84 (0.73-0.96) 0.82 (0.65-1.04) 0.89 (0.70-1.14) 0.90 (0.71-1.14) 
Age <65 years       
   Inactive¶ 71 402 39 0.55 (0.40-0.75) 1.00 1.00 1.00 
   Active** 199 618 102 0.51 (0.42-0.62) 1.00 (0.69-1.45) 1.10 (0.75-1.59) 1.10 (0.76-1.60) 
Age ≥65 years       
   Inactive¶ 21 363 68 3.18 (2.05-4.04) 1.00 1.00 1.00 
   Active** 49 068 106 2.16 (1.79-2.61) 0.70 (0.52-0.96) 0.75 (0.54-1.03) 0.76 (0.55-1.04) 
CI confidence interval, DVT deep vein thrombosis, HR hazard ratio, IR incidence rate, PE pulmonary embolism 
*Per 1000 person-years 
†Adjusted for age (as timescale) and sex 
‡Model 1 + body mass index 
§Model 2 + history of cardiovascular disease and cancer 
¶<1 hour/week of physical activity 
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Table 7 Total, direct and indirect (mediated via body mass index) effects of physical activity status on 
the risk of VTE derived from the Aalen additive hazard model. The Tromsø Study (1994-2016) 
 
Direct effect 
(95% CI) x 10-3*† 
Indirect effect 
(95% CI) x 10-3*† 
Total effect 
(95% CI) x 10-3*† 
Indirect/total effect 
(95% CI) 
All     
Active‡ versus inactive§ -0.32 (-0.64 to 0.006) -0.10 (-0.13 to -0.06) -0.42 (-0.73 to -0.14) 0.23 (0.11 to 0.68) 
Age <65 years     
Active‡ versus inactive§ -0.07 (-0.33 to 0.20) -0.07 (-0.10 to -0.04) -0.20 (-0.42 to -0.07) 0.36 (0.15 to 0.90) 
Age ≥65 years     
  Active‡ versus inactive§ -1.35 (-2.54 to -0.16) -0.22 (-0.37 to -0.09) -1.59 (-2.74 to -0.52) 0.14 (0.05 to 0.48) 
 
CI confidence interval, VTE venous thromboembolism 
*Per year 
†Adjusted for age (as timescale) and sex 
‡≥1 hour/week of physical activity 





Fig. 1. Overview of study participation (dots) and observation periods (arrows). In total, 30 002 
individuals were included in the study. Of these, 18 064 participated in one survey, 8541 participated 
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